Drug Shortage Report for MINT-LOSARTAN
Report ID | 113190 |
Drug Identification Number | 02405768 |
Brand name | MINT-LOSARTAN |
Common or Proper name | losartan |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 100.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 count bottles |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-09-27 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-04-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-04-25 | French | Compare |
v1 | 2020-04-25 | English | Compare |
Showing 1 to 2 of 2